secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sharps Technology Inc. (STSS)
CIK:        0001737995
Form:       8-K
Filed at:   2024-12-05T23:59:59+00:00
Accession:  0001493152-24-048823
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Sharps Technology signs $50M+ SoloGard syringe deal; sets $5M 2025 revenue target
--------------------------------------------------------------------------------

- Entered $50M+ 5-year supply agreement for 500M SoloGard 10mL syringes with U.S. pharma company; deliveries begin Q1 2025.
- Signed sales agreement with European medical supply company for SecureGard 1mL/3mL inventory; first revenue in early December 2024.
- Revenue guidance: ~$400K Dec 2024, >$5M in 2025, $15M in 2026, $20M in 2027 from Hungary facility.
- Regained compliance with NASDAQ listing rules as of November 13, 2024.
- Hungary expansion targets SecureGard capacity >100M units and SoloGard >125M units annually.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737995/000149315224048823/0001493152-24-048823-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737995/000149315224048823/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-048823

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer